These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4736494)

  • 1. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Sonninen V; Riekkinen P; Rinne UK
    Neurology; 1973 Jul; 23(7):760-3. PubMed ID: 4736494
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine accumulation among sclerotic patients receiving dorsal-column stimulation.
    Cook A; Nidzgorski F; Hurwic M; Winsberg B; Klutch A
    Lancet; 1978 Jan; 1(8054):46. PubMed ID: 74526
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O; Johansson BB; Svennerholm L
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluid.
    Kartzinel R; Ebert MH; Chase TN
    Neurology; 1976 Oct; 26(10):992-6. PubMed ID: 134293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis.
    Claveria LE; Curzon G; Harrison MJ; Kantamaneni BD
    J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):715-8. PubMed ID: 4844138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatographic determination of homovanillic acid, 5-hydroxyindoleacetic acid and probenecid levels in human cerebrospinal fluid during probenecid test.
    Gagnieu MC; Menouni-Foray V; Guardiola P; Quincy C; Renaud B
    Clin Chim Acta; 1984 May; 139(1):1-12. PubMed ID: 6202442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cerebrospinal monoamine metabolites in children using the probenecid method.
    Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
    Isr Ann Psychiatr Relat Discip; 1977; 15(1):47-57. PubMed ID: 268307
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D; Pullar IA; Mawdsley C; Kinloch N; Yates CM
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease.
    Gottfries CG; Kjällquist A; Pontén U; Roos BE; Sundbärg G
    Br J Psychiatry; 1974 Mar; 124(0):280-7. PubMed ID: 4836896
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
    Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
    [No Abstract]   [Full Text] [Related]  

  • 12. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment.
    Sjöström R
    Eur J Clin Pharmacol; 1973 Aug; 6(2):75-80. PubMed ID: 4588853
    [No Abstract]   [Full Text] [Related]  

  • 15. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 16. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of a child with familial dysautonomia.
    Andersson H; Hagne I; Roos BE
    Acta Paediatr Scand; 1973 Jan; 62(1):46-8. PubMed ID: 4691255
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
    Stelmasiak Z
    Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248
    [No Abstract]   [Full Text] [Related]  

  • 19. Lumbar cerebrospinal fluid homovanillic acid concentrations are higher in female than male non-human primates.
    Seegal RF
    Brain Res; 1985 May; 334(2):375-9. PubMed ID: 2581673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.